AI-assisted psychedelic care is emerging as a companion to therapists, with tools for preparation, integration, monitoring, and scalable support between sessions

AI-assisted psychedelic care is being positioned as a complement to therapists rather than a replacement. The focus is on preparation, integration, symptom check-ins, journaling support, pattern tracking, and between-session guidance that can expand access while preserving human clinical judgment. Digital tools can help patients organize intentions, recall insights, monitor mood changes, and surface risks or themes that deserve follow-up with a professional. Supporters frame this hybrid model as a way to reduce costs, improve continuity of care, and make psychedelic services more scalable in settings where trained clinicians remain scarce. The central tension is safety, ethics, and trust. Sensitive mental health data, model errors, overreliance on automated advice, and unclear boundaries around crisis support all shape whether AI can be responsibly integrated into psychedelic therapy ecosystems.